Theseus Pharma To Acquire Concentra Biosciences For $4.05/Sh

Biopharmaceutical company Theseus Pharmaceuticals, Inc. (THRX) announced Friday it has entered into a definitive merger agreement whereby Concentra Biosciences, LLC will acquire Theseus for a price per share of Theseus common stock of between $3.

Related Keywords

, Theseus Pharmaceuticals Inc , Concentra Biosciences , Theseus Pharmaceuticals , Contingent Value Rights , Merger Agreement , Thrx , Iopharmaceutical Company Theseus ,